On August 26, 2020 Oncology Venture A/S ("Oncology Venture") (OV:ST) reported that its executive management will host a live webcast on August 28, 2020, at 5:00 p.m. CEST to discuss the company’s second quarter 2020 results and provide a business and financial update (Press release, Oncology Venture, AUG 26, 2020, https://oncologyventure.com/press-release/oncology-venture-a-s-invites-investors-for-q2-2020-report-conference-call/ [SID1234564058]). The webcast will follow the publication of Oncology Venture’s Q2 2020 report, also scheduled for release on August 28, 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Interested parties may register for the event via the Events and Presentations section of the Oncology Venture website at View Source." target="_blank" title="View Source." rel="nofollow">View Source Please connect to the web-conference application prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

Agenda:

General business update by CEO Steve Carchedi
Financial update by CFO Henrik Moltke
Q&A
Pre-submitted questions will be prioritized for the Q&A. To pre-submit a question, please email it to [email protected], no later than 3 pm CEST on 28 August.

Online webcast/conference call:

Attendees are encouraged to pre-register in order to be able to watch the presentation slides using this link:
·View Source